Feb. 5, 2026 — New research shows that the use of an AI-enabled digital stethoscope more than doubled the identification of moderate to severe valvular heart disease during routine clinical ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
Feb. 5, 2026 — New research shows that the use of an AI-enabled digital stethoscope more than doubled the identification ...
Feb. 6, 2026 — Rapid Medical, a developer of active endovascular devices, has announced the latest results from the ...
Feb. 9, 2026 — Argá Medtech has announced positive clinical results from the BURST-AF (NCT05572047) first-in-human trial ...
Feb. 3, 2026 — The first official summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI ...
Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...
Nov. 12, 2025 — The Association of Black Cardiologists (ABC) has released new findings from a national survey exposing a ...
Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...
Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...
Sept. 29, 2025 — Many studies have shown the inverse relationship between bone mineral density (BMD) — the gold standard ...
Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...
Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...
Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...
Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...
Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they ...
Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...
February 11, 2026